Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial

G.S. Falchook; G.V. Long; R. Kurzrock; K.B. Kim; T.H. Arkenau; M.P. Brown; O. Hamid; J.R. Infante; Michael Millward; A.C. Pavlick; S.J. O'Day; S.C. Blackman; C.M. Curtis; P. Lebowitz; B. Ma; D. Ouellet; R.F. Kefford

doi:10.1016/S0140-6736(12)60398-5

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial

G.S. Falchook, G.V. Long, R. Kurzrock, K.B. Kim, T.H. Arkenau, M.P. Brown, O. Hamid, J.R. Infante, Michael Millward, A.C. Pavlick, S.J. O'Day, S.C. Blackman, C.M. Curtis, P. Lebowitz, B. Ma, D. Ouellet, R.F. Kefford

Research output: Contribution to journal › Article › peer-review

835 Citations (Scopus)

Original language	English
Pages (from-to)	1893-1901
Journal	Lancet
Volume	379
DOIs	https://doi.org/10.1016/S0140-6736(12)60398-5
Publication status	Published - 2012

Access to Document

10.1016/S0140-6736(12)60398-5

Cite this

Falchook, G. S., Long, G. V., Kurzrock, R., Kim, K. B., Arkenau, T. H., Brown, M. P., Hamid, O., Infante, J. R., Millward, M., Pavlick, A. C., O'Day, S. J., Blackman, S. C., Curtis, C. M., Lebowitz, P., Ma, B., Ouellet, D., & Kefford, R. F. (2012). Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial. Lancet, 379, 1893-1901. https://doi.org/10.1016/S0140-6736(12)60398-5

@article{382b393c539f4b94b336c30f6886d639,

title = "Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial",

author = "G.S. Falchook and G.V. Long and R. Kurzrock and K.B. Kim and T.H. Arkenau and M.P. Brown and O. Hamid and J.R. Infante and Michael Millward and A.C. Pavlick and S.J. O'Day and S.C. Blackman and C.M. Curtis and P. Lebowitz and B. Ma and D. Ouellet and R.F. Kefford",

year = "2012",

doi = "10.1016/S0140-6736(12)60398-5",

language = "English",

volume = "379",

pages = "1893--1901",

journal = "Lancet",

issn = "0140-6736",

publisher = "Academic Press",

}

Falchook, GS, Long, GV, Kurzrock, R, Kim, KB, Arkenau, TH, Brown, MP, Hamid, O, Infante, JR, Millward, M, Pavlick, AC, O'Day, SJ, Blackman, SC, Curtis, CM, Lebowitz, P, Ma, B, Ouellet, D & Kefford, RF 2012, 'Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial', Lancet, vol. 379, pp. 1893-1901. https://doi.org/10.1016/S0140-6736(12)60398-5

TY - JOUR

T1 - Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial

AU - Falchook, G.S.

AU - Long, G.V.

AU - Kurzrock, R.

AU - Kim, K.B.

AU - Arkenau, T.H.

AU - Brown, M.P.

AU - Hamid, O.

AU - Infante, J.R.

AU - Millward, Michael

AU - Pavlick, A.C.

AU - O'Day, S.J.

AU - Blackman, S.C.

AU - Curtis, C.M.

AU - Lebowitz, P.

AU - Ma, B.

AU - Ouellet, D.

AU - Kefford, R.F.

PY - 2012

Y1 - 2012

U2 - 10.1016/S0140-6736(12)60398-5

DO - 10.1016/S0140-6736(12)60398-5

M3 - Article

SN - 0140-6736

VL - 379

SP - 1893

EP - 1901

JO - Lancet

JF - Lancet

ER -